Active ingredientTribenosideCat. No. P-T192-001CAS 10310-32-4Family · Pharmaceutical analytical standards
Tribenoside
A vasoprotective drug with anti-inflammatory, mildly analgesic and wound-healing activity, used alone or with lidocaine in creams and suppositories to treat haemorrhoids; the first clinical studies date back to the 1970s. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Chemically it is a modified sugar: a glucose molecule carrying three benzyl groups and one ethyl group.
Go to the active ingredient →Active ingredientTribenosideCat. No. P-T192-001CAS 10310-32-4
Pharmacopoeial impurityTribenoside EP Impurity ACat. No. P-T192-002CAS 53928-30-6
Pharmacopoeial impurityTribenoside EP Impurity BCat. No. P-T192-003CAS 28713-39-5
Pharmacopoeial impurityTribenoside EP Impurity DCat. No. P-T192-004CAS 103-50-4
Isotopically labelledTribenoside-d15Cat. No. P-T192-005
ImpurityTribenoside Impurity 1Cat. No. P-T192-006CAS 35958-64-6No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceTribenoside CRSEDQM code Y0000165Family TribenosideImpurityTribenoside impurity A CRSEDQM code Y0000166Family TribenosideImpurityTribenoside impurity D CRSEDQM code Y0001628Family TribenosideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.